2026 Consolidated CDA

ALLERGIES AND ADVERSE REACTIONSNo Known Drug AllergiesNo Known Drug Allergies

MEDICATIONSMedication Start Date Directions Status

mefloquine 250 mg tablet, [RxNorm: 835915]
08/19/2021
TAKE 1 TABLET (250 MG) BY ORAL ROUTE ONCE WEEKLY START 1 WEEK BEFORE DEPARTURE TO ENDEMIC AREA and continue for 4 weeks after return; TAKE WITH FOOD AND AT LEAST 8 OZ. OF WATER 
Active
Ambien 10 mg tablet, [RxNorm: 854875]
08/19/2021

ActivePROBLEMSNo known health problemsENCOUNTERSEncounter Performer Location Date

LIMITED EST PT
Amy Morris
Auburn Montgomery Warhawk Health Services
Feb 26, 2020
BRIEF EST PT
Carol Stewart
Auburn Montgomery Warhawk Health Services
Aug 19, 20217461 East Dr STE 102MontgomeryAL361178092USAuburn Montgomery Warhawk Health Services7461 East Dr STE 102MontgomeryAL361178092USAuburn Montgomery Warhawk Health ServicesPROCEDURESProcedure Date

Twinrix & Hepatitis A/B, [CPT-4: 90636]
07/16/2020
COVID-19, mRNA, LNP-S, PF, [CPT-4: 91300]
02/17/2021
COVID-19, mRNA, LNP-S, PF, [CPT-4: 91300]
03/10/20217461 East Dr STE 102MontgomeryAL361178092USAuburn Montgomery Warhawk Health Services7461 East Dr STE 102MontgomeryAL361178092US7461 East Dr STE 102MontgomeryAL361178092USAuburn Montgomery Warhawk Health Services7461 East Dr STE 102MontgomeryAL361178092US7461 East Dr STE 102MontgomeryAL361178092USAuburn Montgomery Warhawk Health Services7461 East Dr STE 102MontgomeryAL361178092US

            MEDICAL EQUIPMENTPatient has no history of implantable devicesIMMUNIZATIONSName Date Status

Twinrix & Hepatitis A/B
01/15/2020
Completed
Typhoid
01/15/2020
Completed
Twinrix & Hepatitis A/B
02/25/2020
Completed
Twinrix & Hepatitis A/B
07/16/2020
Completed
COVID-19, mRNA, LNP-S, PF
02/17/2021
Completed
COVID-19, mRNA, LNP-S, PF
03/10/2021
CompletedTwinrix & Hepatitis A/B3PP42GlaxoSmithKline7461 East DrMontgomeryALUSCarolStewartNPAuburn Montgomery Student Health Services7461 East DrMontgomeryAL36117USTyphoidR1B731MSanofi Pasteu7461 East DrMontgomeryALUSCarolStewartNPAuburn Montgomery Student Health Services7461 East DrMontgomeryAL36117USTwinrix & Hepatitis A/B3Y7NLGlaxoSmithKline7461 East DrMontgomeryALUSCarolStewartNPAuburn Montgomery Student Health Services7461 East DrMontgomeryAL36117USTwinrix & Hepatitis A/B3Y7NLGlaxoSmithKline7461 East DrMontgomeryALUSCarolStewartNPAuburn Montgomery Student Health Services7461 East DrMontgomeryAL36117USCOVID-19, mRNA, LNP-S, PFEN6200Pfizer, Inc7461 East DrMontgomeryALUSCarolStewartNPAuburn Montgomery Student Health Services7461 East DrMontgomeryAL36117USCOVID-19, mRNA, LNP-S, PFEN6205Pfizer, Inc7461 East DrMontgomeryALUSCarolStewartNPAuburn Montgomery Student Health Services7461 East DrMontgomeryAL36117USVITAL SIGNSDate Height Weight BMI Blood Pressure Temperature Pulse Pulse Oximetry Respiratory Rate Inhaled Oxygen Concentration Head Circumference Percentage BMI Percentage Weight to Length Percentage

07/16/2020 36 Cel
08/19/2021 130 cm 78 kg 46.57 118/78 mm[Hg] 37 Cel 101 bpm 97 pct 16 bpmRESULTSLaboratory Values/Results: No Lab Result dataTREATMENT PLANName Type Date

Prescription
TAKE 1 TABLET (250 MG) BY ORAL ROUTE ONCE WEEKLY START 1 WEEK BEFORE DEPARTURE TO ENDEMIC AREA and continue for 4 weeks after return; TAKE WITH FOOD AND AT LEAST 8 OZ. OF WATER 
August 19, 2021TAKE 1 TABLET (250 MG) BY ORAL ROUTE ONCE WEEKLY START 1 WEEK BEFORE DEPARTURE TO ENDEMIC AREA and continue for 4 weeks after return; TAKE WITH FOOD AND AT LEAST 8 OZ. OF WATER Goals SectionNo goal informationHealth Concerns SectionNo Known Health Concerns on INSTRUCTIONSNo Known Instructions/Patient EducationSOCIAL HISTORYNo Social History Selected to be DisplayedFUNCTIONAL STATUSNo informationMENTAL STATUSNo information

Medication	Start Date	Directions	Status
mefloquine 250 mg tablet, [RxNorm: 835915]	08/19/2021	TAKE 1 TABLET (250 MG) BY ORAL ROUTE ONCE WEEKLY START 1 WEEK BEFORE DEPARTURE TO ENDEMIC AREA and continue for 4 weeks after return; TAKE WITH FOOD AND AT LEAST 8 OZ. OF WATER	Active
Ambien 10 mg tablet, [RxNorm: 854875]	08/19/2021		Active

Encounter	Performer	Location	Date
LIMITED EST PT	Amy Morris	Auburn Montgomery Warhawk Health Services	Feb 26, 2020
BRIEF EST PT	Carol Stewart	Auburn Montgomery Warhawk Health Services	Aug 19, 2021

Procedure	Date
Twinrix & Hepatitis A/B, [CPT-4: 90636]	07/16/2020
COVID-19, mRNA, LNP-S, PF, [CPT-4: 91300]	02/17/2021
COVID-19, mRNA, LNP-S, PF, [CPT-4: 91300]	03/10/2021

Name	Date	Status
Twinrix & Hepatitis A/B	01/15/2020	Completed
Typhoid	01/15/2020	Completed
Twinrix & Hepatitis A/B	02/25/2020	Completed
Twinrix & Hepatitis A/B	07/16/2020	Completed
COVID-19, mRNA, LNP-S, PF	02/17/2021	Completed
COVID-19, mRNA, LNP-S, PF	03/10/2021	Completed

Date	Height	Weight	BMI	Blood Pressure	Temperature	Pulse	Pulse Oximetry	Respiratory Rate	Inhaled Oxygen Concentration	Head Circumference Percentage	BMI Percentage	Weight to Length Percentage
07/16/2020	36 Cel
08/19/2021	130 cm	78 kg	46.57	118/78 mm[Hg]	37 Cel	101 bpm	97 pct	16 bpm